U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H13N3O3
Molecular Weight 259.2606
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYCLOBENDAZOLE

SMILES

COC(=O)NC1=NC2=CC(=CC=C2N1)C(=O)C3CC3

InChI

InChIKey=OXLKOMYHDYVIDM-UHFFFAOYSA-N
InChI=1S/C13H13N3O3/c1-19-13(18)16-12-14-9-5-4-8(6-10(9)15-12)11(17)7-2-3-7/h4-7H,2-3H2,1H3,(H2,14,15,16,18)

HIDE SMILES / InChI

Molecular Formula C13H13N3O3
Molecular Weight 259.2606
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Doses

Doses

DosePopulationAdverse events​
1200 mg single, oral
Highest studied dose
Dose: 1200 mg
Route: oral
Route: single
Dose: 1200 mg
Sources:
unhealthy, UNKNOWN
Health Status: unhealthy
Age Group: UNKNOWN
Sex: unknown
Food Status: UNKNOWN
Sources:
Other AEs: Vomiting, Diarrhoea...
Other AEs:
Vomiting
Diarrhoea
Sources:
AEs

AEs

AESignificanceDosePopulation
Diarrhoea
1200 mg single, oral
Highest studied dose
Dose: 1200 mg
Route: oral
Route: single
Dose: 1200 mg
Sources:
unhealthy, UNKNOWN
Health Status: unhealthy
Age Group: UNKNOWN
Sex: unknown
Food Status: UNKNOWN
Sources:
Vomiting
1200 mg single, oral
Highest studied dose
Dose: 1200 mg
Route: oral
Route: single
Dose: 1200 mg
Sources:
unhealthy, UNKNOWN
Health Status: unhealthy
Age Group: UNKNOWN
Sex: unknown
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives.
1997-12
Comparative trial on the therapeutic effectiveness of the new anthelmintic drug: ciclobendazole.
1978-12
Patents

Sample Use Guides

In Vivo Use Guide
Oxyuriasis treatment: 50 children were treated twice with 100 mg of cyclobendazole each, at a weekly interval
Route of Administration: Oral
In Vitro Use Guide
Cyclobendazole inhibited G. lamblia growth with IC50 0.047 ug/ml.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:24:31 GMT 2025
Edited
by admin
on Mon Mar 31 18:24:31 GMT 2025
Record UNII
JF3KQ40J31
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CICLOBENDAZOLE
INN   MART.   WHO-DD  
INN  
Preferred Name English
CYCLOBENDAZOLE
MI   USAN  
USAN  
Official Name English
CYCLOBENDAZOLE [USAN]
Common Name English
CARBAMIC ACID, (5-(CYCLOPROPYLCARBONYL)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
Common Name English
ciclobendazole [INN]
Common Name English
NSC-335307
Code English
CICLOBENDAZOLE [MART.]
Common Name English
Methyl 5-(cyclopropylcarbonyl)-2-benzimidazolecarbamate
Common Name English
R-17147
Code English
R 17,147
Code English
CYCLOBENDAZOLE [MI]
Common Name English
Ciclobendazole [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C250
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
WHO-ATC P02CA04
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
Code System Code Type Description
CAS
31431-43-3
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
WIKIPEDIA
CICLOBENDAZOLE
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
DRUG BANK
DB13465
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
NSC
335307
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
FDA UNII
JF3KQ40J31
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
MERCK INDEX
m3975
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID9057713
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
DRUG CENTRAL
3120
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
EVMPD
SUB06240MIG
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
ECHA (EC/EINECS)
250-637-5
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
PUBCHEM
35803
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
SMS_ID
100000081906
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
NCI_THESAURUS
C78041
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
INN
3570
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
ChEMBL
CHEMBL1788401
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
MESH
C014415
Created by admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY